FDA Inspection 1303428 - Waylis Therapeutics - February 12, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Waylis Therapeutics, with an inspection on February 12, 2026, issued by the New Jersey District Office, covering human drugs.

Company: Waylis Therapeutics
Inspection Date: February 12, 2026
Product Type: Human Drugs
Office: New Jersey District Office

Open in Dashboard

ID · 9556879f-5f81-4433-881b-59a74b649726

Violation Codes1

21 CFR 314.80(b)

Full citation text and observation details available on the Dashboard.